ERIC I. RICHMAN - 09 Sep 2022 Form 4 Insider Report for NeuBase Therapeutics, Inc. (NBSE)

Role
Director
Signature
/s/ Dietrich A. Stephan, as attorney-in-fact for Eric I. Richman
Issuer symbol
NBSE
Transactions as of
09 Sep 2022
Transactions value $
$0
Form type
4
Filing time
12 Sep 2022, 17:01:53 UTC
Previous filing
27 May 2022
Next filing
22 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NBSE Stock option (right to buy) Award $0 +37.6K $0.00 37.6K 09 Sep 2022 Common Stock 37.6K $0.60 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the total shares shall vest on the first anniversary of September 9, 2022, and the remaining shares shall vest on an equal monthly basis over the following 36 months.

Remarks:

The power of attorney under which this form was signed is on file with the Commission.